Sandoz chief steps down

Richard Francis, CEO of Novartis’s generic unit Sandoz, is stepping down as the company begins restructuring the division. Francesco Balestrieri, currently Sandoz’s Europe region head, was appointed interim CEO.

Forma Therapeutics CEO departs

Steve Tregay, founder and CEO of Forma Therapeutics, is moving into an advisory role. Frank Lee, who previously led global product strategy and immunology, ophthalmology, and infectious disease areas at Genentech, was named CEO.

CMI/Compas promotes leaders

CMI/Compas chief commercial officer Susan Dorfman was promoted to president of CMI Media. John Donovan, formerly CFO, was named president of Compas.

Orchard brings on Zheng

Amgen veteran Ran Zheng hasjoined Orchard Therapeutics in the newly created role of chief technical officer. She was previously Amgen’s VP of development supply chain.

Fontenot joins Sangamo Therapeutics

Jason Fontenot has joined Sangamo Therapeutics as head of cell therapy. Previously, he served as chief scientific officer at Immusoft.

Sienna Biopharmaceuticals promotes Azoy

Sienna Biopharmaceuticals has promoted Alexander Azoy to CFO. He formerly served as the company’s controller.

Client-side people moves courtesy of MM&M sister brand The PMD.

The Escalator is a weekly roundup of notable people moves in the pharmaceutical and healthcare marketing industries. For submissions, email Frank Washkuch at